|
Veterinary Carbasalate Calcium APIIn 2026, Sanray has become China¡¯s leading distributor of veterinary Carbasalate Calcium, managing annual sales of over 2,000 metric tons and serving the sourcing needs of veterinary pharmaceutical manufacturers and qualified business partners in China and international markets. This product marks a milestone for Sanray in Veterinary API business. We work with customers seeking a dependable supply partner for veterinary pharmaceutical raw materials, with product information, quality documentation, and commercial support tailored to their procurement requirements. A Water-soluble Non-Steroidal Anti-inflammatory Drug Carbasalate calcium API is an aspirin-related pharmaceutical substance used in veterinary formulations where authorized. It is an antipyretic, analgesic, and anti-inflammatory drug used for the symptomatic treatment of febrile diseases, pain, and various infections in pigs. It is currently the only antipyretic, analgesic, and anti-inflammatory drug approved for oral administration in livestock and poultry in China. It is characterized by rapid absorption, quick onset of action, high bioavailability, and no residual drug residues. (1) Analgesic and Anti-inflammatory Effects (2) Anti-Stress Effects (3) Anti-Endotoxin Effects Why Work with Sanray? Sanray holds sales authorization for carbasalate calcium from the existing major manufacturers in China. We have built trust among these manufacturers to maintain a sustainable and healthy marketing environment. Dedicated B2B Supply Support We communicate directly with customers regarding product requirements, quotations, procurement planning, and available documentation. Product Documentation on Request Relevant product specifications and available quality documents can be provided for customer evaluation, subject to availability and applicable confidentiality requirements. China and International Market Coverage We welcome inquiries from veterinary pharmaceutical manufacturers and qualified distributors in China and overseas markets, subject to applicable export, import, and regulatory requirements. Contact: amy.meng@sanraypharm.com; Veronica.lu@sanraypharm.com; zhangjingkun@sanraypharm.com |